Pathophysiology of vascular disease in diabetes: effects of gliclazide.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Medicine

• Publication date

  1991-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(91)90418-WPMID 1872305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Cardiovascular Risk Factors in Prevention and Treatment of Macrovascular Disease in Diabetes

  1989cited by this paper
• Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.

  1989cited by this paper
• Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.

  1988cited by this paper
• Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients.

  1988cited by this paper
• Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas.

  1988cited by this paper
• Antisperm antibodies in infertility

  1988cited by this paper
• Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.

  1988cited by this paper
• A review of the development of large-vessel disease in diabetes mellitus.

  1988cited by this paper
• Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study.

  1987cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.

  1984cited by this paper
• New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.

  1983cited by this paper
• The effects of gliclazide on platelet function in patients with diabetes mellitus.

  1982cited by this paper
• [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].

  1982cited by this paper
• Sulfonylureas and platelet function.

  1981cited by this paper
• Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.

  1981cited by this paper
• Atherosclerosis in diabetes mellitus.

  1981cited by this paper
• Pathogenesis of Atherosclerosis in Diabetes Mellitus

  1981cited by this paper
• Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.

  1979cited by this paper
• Gliclazide in the treatment of diabetic retinopathy.

  1979cited by this paper
• The pathogenesis of atherosclerosis (first of two parts).

  1976cited by this paper

• Sodium‐Glucose Cotransporter‐2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation

  2023cites this paper
• The Inflammation Markers According to the Presence of Coronary Artery Disease in Patients with Peripheral Artery Disease

  2013cites this paper
• A brief review on the pathogenesis of human diabetic neuropathy: Observations and Postulations

  2005influential citation
• Platelet abnormalities in diabetes mellitus

  2003cites this paper
• Controversies in Management of Diabetes in Patients with Coronary Heart Disease

  2002cites this paper
• Insulin Treatment in Type 2 Diabetes

  2001cites this paper
• Tratamiento de la diabetes tipo 2. Fármacos insulinosecretores

  2000cites this paper
• Antidiabetic Drugs Present and Future

  2000cites this paper
• Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?

  2000cites this paper
• Vascular evaluation of the problem diabetic foot.

  1998cites this paper
• Cerebrovascular responsiveness to NG‐nitro‐L‐arginine methyl ester in spontaneously diabetic rats

  1996cites this paper
• Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

  1996cites this paper
• Antiphospholipid Antibodies in Coronary Artery Disease: A Review

  1994cites this paper
• Altered distribution of some surface glycosaminoglycans and glycoconjugates on human blood platelets in diabetes mellitus.

  1994cites this paper
• Platelet abnormalities in diabetes mellitus.

  1993cites this paper
• Gliclazide: metabolic and vascular effects--a perspective.

  1992cites this paper
• Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus.

  1992cites this paper